return to news
  1. Upstox
    /
  2. News
    /
  3. Market News
    /
  4. Earnings
    /
  5. Zydus Wellness Q4 results: Net profit falls 6% YoY to ₹162 crore, EBITDA surges 42%; dividend recommended

Market News

Zydus Wellness Q4 results: Net profit falls 6% YoY to ₹162 crore, EBITDA surges 42%; dividend recommended

Abha Raverkar
By Abha Raverkar

3 min read | Updated on May 18, 2026, 14:58 IST

Google
SelectUpstoxas yourPreferred news source
Copy link
Twitter Page
Linkedin Page
Whatsapp Page

SUMMARY

Zydus Wellness Q4 earnings: Its revenue from operations stood at ₹1,484.7 crore in the latest March quarter, marking a 62.59% YoY jump from ₹913.1 crore in Q4 FY25.

Stock list

ZYDUSWELL
--
Zydus Wellness Q4 results

The company’s board of directors also recommended a final dividend of ₹1.20 per equity share. | Image: Shutterstock

Zydus Wellness Q4 results: Zydus Wellness on Monday, May 18, reported its earnings for the fourth quarter of the 2025-26 financial year (Q4 FY26), posting a 5.75% year-on-year (YoY) decline in its consolidated net profit to ₹162 crore.
Open FREE Demat Account within minutes!
Join now

In the corresponding period of the previous fiscal year, it had logged a profit of ₹171.9 crore, according to a regulatory filing.

Its revenue from operations stood at ₹1,484.7 crore during the quarter under review, marking a 62.59% YoY jump from ₹913.1 crore in the March quarter of the 2024-25 fiscal year (Q4 FY25).

At an operational level, its EBITDA (earnings before interest, tax, depreciation and amortisation), also known as operating profit, surged 42.2% YoY to ₹270.1 crore in Q4 FY26, compared to ₹190 crore in the year-ago period.

Its EBITDA margin, however, contracted to 18.2% in the reporting quarter, as against 20.8% in the fourth quarter of FY25.

Q4 snapshots

Its sugar-free segment strengthened its leadership in the sugar substitute category, with a market share of 96.1%. Sugar Free Green delivered its 20th consecutive quarter of double-digit growth.
Zydus Wellness’s RiteBite –Max Protein business continued to outperform while maintaining its leadership in protein snacking and improving EBITDA from breakeven at the time of acquisition a year ago to near double-digit margins.
“Glucon-D maintained its leadership position with a 58.9%* MAT market share. Glucon-D entered the performance hydration category with the launch of ‘Glucon-D Recharge’ in Liquid and Sachet formats, offering three flavours across the portfolio, targeting active and health-conscious consumers,” it said.
Its Everyuth business leads with 48.6% share in scrubs and 75.5% in peel-off masks, ranking fifth in the facial cleansing segment with an 8% share. It delivered strong double-digit growth in FY26, driven by innovation, distribution expansion, and enhanced consumer experience, with tan removal further strengthening its saliency, supported by the Q4 launch of its tan-removal face wash.
Its Nutralite segment delivered double-digit growth, supported by a strong six-year compound average growth rate (CAGR) and consistent performance across the portfolio, while maintaining leadership in the fat spread category. Complan maintained its fourth rank, holding a 4% market share.
The company’s Comfort Click business expanded its portfolio with 11 product launches in Weightworld and Animigo, strengthening its presence in high-growth markets. During the quarter, WeightWorld and Maxmedix expanded their channel presence in the UAE market through a leading e-commerce platform.

Final dividend recommended; check record date

The company’s board of directors also recommended a final dividend of ₹1.20 per equity share, at a rate of 60%, with a face value of ₹2 each for FY26, subject to approval of the members at the ensuing Annual General Meeting (AGM), which is scheduled to be held on Tuesday, August 4, 2026.

Furthermore, it fixed Friday, July 17, 2026, as the record date for the same.

“The company shall make the payment of dividend, subject to deduction of applicable tax at source, on or after Friday, August 7, 2026, subject to the approval of the same by the members at the ensuing AGM,” Zydus Wellness said.

Shares of Zydus Wellness continued to trade in the red, following its result announcement, on the back of a broad-based sell-off in the market.

At around 2:51 PM, the stock was trading 1.77% lower at ₹493.25 per equity share on the National Stock Exchange (NSE) on Monday.

Zydus Wellness has a total market capitalisation of ₹15,688.51 crore as of May 18, 2026, according to data on the NSE.

About The Author

Abha Raverkar
Abha Raverkar is a post-graduate in economics from Christ University, Bengaluru. She has a strong interest in the markets and loves to unravel the nitty-gritties of the latest happenings in the world of markets, business, and the economy.

Next Story